A Phase 4 Multicenter, Randomized, Open-Label, Interventional Study With Pragmatic Elements Investigating the Effectiveness of Tirzepatide Once Weekly Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes in a Real-World Setting
A Phase 4 Multicenter, Randomized, Open-Label, Interventional Study With Pragmatic Elements Investigating the Effectiveness of Tirzepatide Once Weekly Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes in a Real-World Setting
The purpose of this study is to evaluate tirzepatide within a real-world setting to assess body weight loss and incidence of type 2 diabetes in adults without diabetes who have obesity and at least one weight-related comorbid condition. Participation in the study will last about 260 weeks.
Inclusion Criteria:
Exclusion Criteria:
LillyTrials@Lilly.com317-615-4559
clinical_inquiry_hub@lilly.com
Cheshire, M33 7SS, United Kingdom
Cheshire, SK8 5LL, United Kingdom
Hyde SK14, SK14 1AT, United Kingdom
Wigen, WN7 2PE, United Kingdom